City

Houston (1)

Condition

Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma (1)

Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma (1)

Sinonasal Undifferentiated Carcinoma (1)

Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8 (1)

Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8 (1)

Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8 (1)

Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8 (1)

Overall Status

Recruiting (1)

Phase

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

carboplatin (1)

chemoradiotherapy (1)

cisplatin (1)

definitive surgical resection (1)

docetaxel (1)

fluorouracil (1)

quality-of-life assessment (1)

radiation therapy (1)

Study Documents

Intervention Type

drug (1)

other (1)

procedure (1)

radiation (1)

Funder Type

Other (1)

Study Type

Interventional (1)

nasal cavity and paranasal sinus poorly differentiated carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly

Recruiting

Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
+6 more

Carboplatin
+7 more

Houston, Texas

M D Anderson Cancer Center

Jul 23, 2021